Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

Topotecan 2Drug Therapy 2sintilimab 1dinutuximab 1atezolizumab 1Temozolomide 1SR 48692 1Rabeprazole 1Irinotecan 1Etoposide 1Electroporation 1EC regimen 1E-3810 1Cryosurgery 1Carboplatin 1Bevacizumab 12,2',4,4',5-pentachlorodiphenyl ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × 2,2',4,4',5-pentachlorodiphenyl ether × Clear all
NCT00930891 2016-03-10

CPC

Intergroupe Francophone de Cancerologie Thoracique

Phase 2/3 Completed
143 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡